How Long Does It Take to Lose Weight on Semaglutide?

When do people typically start noticing weight loss on semaglutide?

A question our prescribers hear most weeks is some version of: 'I've been on it two weeks, why haven't I lost much yet?' The honest answer is that the first four to eight weeks of semaglutide treatment are primarily about tolerance, not transformation. The starting dose of 0.25mg is too low to produce significant weight loss on its own; its job is to let your digestive system adjust to the medicine before the dose increases.

Many people do notice reduced appetite fairly quickly. Meals feel satisfying with less food, cravings for snacks quieten, and the pull towards high-calorie foods can soften. You might see a small drop on the scales in the first month (commonly two to four pounds in people who weren't already eating very little) but this is not the full picture of what semaglutide can do.

Weight loss tends to accelerate as the dose rises. For most patients on the standard titration schedule, the 1mg and 1.7mg doses mark a noticeable upturn in progress. The pattern in the STEP 1 trial, published in the New England Journal of Medicine, showed the steepest rate of loss occurring roughly between weeks eight and forty, with results plateauing as participants neared the end of the 68-week study period.

If you are curious how the Wegovy timeline compares in more detail, this overview of Wegovy weight-loss timelines walks through the titration stages week by week.

Does the titration schedule change how quickly you lose weight?

Yes, substantially. Semaglutide for weight management (Wegovy) follows a stepped dose schedule: 0.25mg for four weeks, then 0.5mg, 1mg, 1.7mg and finally 2.4mg, with roughly four weeks at each level. The total titration period before reaching the maintenance dose is approximately sixteen to twenty weeks.

This matters for timelines because the appetite-suppressing and metabolic effects of semaglutide are dose-dependent. At 0.25mg and 0.5mg the effect is mild in most people. The 1mg to 1.7mg range is where many patients report their appetite dropping meaningfully. The full 2.4mg maintenance dose is where the STEP 1 evidence is anchored, meaning the average 15% weight loss reported in the trial reflects what happens across the whole treatment period, including the ramp-up phase.

A prescriber may slow the titration if side effects are a problem, which can push the timeline out. That is a reasonable clinical decision, not a setback, keeping someone on treatment for longer at a lower dose is often better than pushing to 2.4mg too quickly and causing them to stop altogether. The NHS semaglutide patient information page gives a clear summary of the dose schedule and what to expect at each stage.

To understand more about how the medicine itself works before the weight-loss effects become visible, this piece on how long semaglutide takes to work covers the mechanism in more detail.

How much weight can you realistically expect to lose, and over what timeframe?

The STEP 1 trial is the clearest reference point: 1,961 adults with obesity or overweight and at least one weight-related condition, taking 2.4mg semaglutide weekly alongside lifestyle support for 68 weeks. The average weight reduction was approximately 15% of starting body weight. That translates, for someone weighing 100kg at the start, to around 15kg over roughly sixteen months.

Results varied across participants. Some lost considerably more, some less. The trial excluded people with type 2 diabetes, whose average losses tend to be somewhat lower. Weight loss was not linear: the first few months showed faster progress as appetite fell sharply, with the pace slowing as the body adapted and as participants approached their new stable weight.

A newer, higher maintenance dose (7.2mg) was approved by the MHRA in early 2026 and showed around 20.7% average weight loss over 72 weeks in trials, approaching the results seen with tirzepatide at its highest dose. If you are thinking about longer targets, this page on losing 40 pounds on Wegovy gives a grounded sense of what that kind of loss usually requires in terms of time and dose.

For context on what private treatment costs in the UK, the Wegovy cost page sets out what is typically included in a private prescription service and the range of prices patients encounter. How long treatment runs also affects overall cost, so the two questions are worth reading together.

What affects whether you lose weight faster or more slowly?

Starting BMI plays a role: people with higher starting weights often lose more in absolute terms but similar percentages. Adherence to the dose schedule matters too. Missing injections, stopping and restarting, or staying at a lower dose longer than planned all slow progress. Diet and activity levels alongside the medicine are not optional extras, the licence and the trial both specify semaglutide as an adjunct to reduced-calorie eating and increased physical activity.

Some people are slower responders to GLP-1 medicines generally. If less than 5% of starting weight has been lost after six months at the maintenance dose, clinical guidelines suggest reviewing whether to continue. That review is a conversation with your prescriber, not an automatic stop, there may be reasons to continue, or reasons to consider a different treatment.

Biological factors including sleep, stress, other medications and underlying conditions all influence the pace of change. No timeline is guaranteed. More on individual factors affecting semaglutide weight loss is covered in our broader semaglutide results guide, and our Wegovy treatment overview sets out everything from eligibility to what the treatment pathway looks like in practice.

If you are ready to explore whether semaglutide is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your details the same day.